Webinar: Filtering through the impact of chronic kidney disease on CVD
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in people living with chronic kidney disease (CKD). Even after adjusting for traditional risk factors, CVD is associated with an increased risk of all-cause and cardiovascular mortality.1 There is an independent inverse association between reduced estimated glomerular filtration rate (eGFR) and, albuminuria, and increased cardiovascular mortality.2,3
Comorbidities such as CVD and diabetes are common in people living with CKD, as are traditional cardiovascular risk factors such as dyslipidaemia and hypertension.3 For individuals with CKD, regular CVD risk assessment is critical.
Hosted live by the Heart Foundation in partnership with the World Heart Federation, this webinar explores the latest evidence on CVD and CKD. Expert panellists unpack the role of early detection of renal risk factors for CVD, as well as pharmacological strategies for the prevention and management of the two conditions.
Duration: 1 hour
Date recorded: 29 September 2022
Topics covered:
- The role of early detection of renal risk factors for cardiovascular disease
- Optimal management of lipids and blood pressure to slow progression of CKD and lower CVD risk
- Explore the association between chronic kidney disease and cardiovascular disease in First Nations people
- Multidisciplinary care for individuals living with CKD and CVD risk factors in general practice
Expert panelists
George Bakris
Professor of Medicine, University of Chicago
Dr. Bakris is a Nephrologist/Certified Hypertension Specialist trained at the Mayo Clinic and the University of Chicago Medicine. He is a Professor of Medicine and Director of the Am. Heart Assoc. Comprehensive Hypertension Centre at the University of Chicago Medicine. He has published over 900 peer-reviewed articles and book chapters in diabetic kidney disease, hypertension, and nephropathy progression. He is the Editor or Co-Editor of 23 books in the areas of Diabetic Kidney Disease Progression and Hypertension. Additionally, he is the Co-Editor of the 3rd and new 4th edition of Hypertension: A Companion to Braunwald’s: The Heart. He has served on the FDA Cardiorenal Advisory Board and consultant to CMS. He has also served on many national guideline committees, including The Joint National Committee JNC 7 writing group, the ADA Clinical Practice Guideline Committee.
Merlin Thomas
Clinician Scientist & Program Leader, Department of Diabetes at Monash University
Professor Merlin Thomas is a clinician scientist and program leader in the Department of Diabetes at Monash University. He is also founder and Chief Scientific Officer of RAGE Biotech Ltd that is commercializing his discoveries. Dr Thomas is renowned as a researcher, educator and medical storyteller with over 300 peer-reviewed publications, as well as author of bestselling books, “The Longevity List” and “Fast Living Slow Ageing”. He is also recognized as a Fellow of the Australian Academy of Health Medical Science. His research program is focused on understanding the mechanisms of diabetic complications and developing new opportunities for their prevention and treatment.
William Majoni
Senior Staff Specialist in Nephrology & Internal Medicine & Director of Renal Services, Top End Health Services
Professor William Majoni is a Senior Staff Specialist in Nephrology and Internal Medicine and Director of Renal Services for Top End Health Service at the Royal Darwin and Palmerston Hospitals in Darwin, Australia. He is also a Clinical Fellow with the Menzies School of Health Research, an adjunct Professor with Charles Darwin University and A/Prof with the Flinders University Northern Territory Medical Program. His research interests include Indigenous health, the epidemiology of renal, infectious, diabetes and cardiovascular diseases, access to transplantation and clinical trials to improve the evidence base for treatment of renal, infectious, diabetes and cardiovascular disease.
Alison Edwards
General Practitioner, Broughton Clinic SA
Dr Alison Edwards has been a rural GP in Port Broughton South Australia for nearly 30 years. She was Clinical Chair of the Australian Primary Care Collaborative Wave 10 2014-2015 focused on chronic kidney disease and cardiovascular disease screening, prevention & management. She has been drowning in COVID-19 mitigation, immunisation and management for the last few years but still tries to keep a watchful eye on those with chronic health conditions and associated risk factors to keep her local community as healthy as possible. She is also Event Director for her local Port Broughton parkrun.
This event was hosted in partnership with the World Heart Federation.
References
- Matsushita K, van der Velde M, B.C. Astor et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375(9731):2073-81. doi:10.1016/S0140-6736(10)60674-5
- Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305. doi:10.1056/NEJMoa041031
- Australian Institute of Health and Welfare. Chronic kidney disease: Australian Facts. 2022.
Last updated21 February 2024